Ohio Public Employees Retirement System (OPERS)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.46M Sell
46,030
-1,568
-3% -$124K 0.01% 826
2025
Q4
$3.77M Sell
47,598
-947
-2% -$71.3K 0.01% 818
2025
Q3
$3.18M Buy
48,545
+301
+0.6% +$14.7K 0.01% 892
2025
Q2
$1.91M Buy
48,244
+67
+0.1% +$2.19K 0.01% 1123
2025
Q1
$1.45M Sell
48,177
-5,571
-10% -$182K 0.01% 1201
2024
Q4
$1.88M Sell
53,748
-3,077
-5% -$115K 0.01% 1156
2024
Q3
$2.28M Buy
56,825
+1,529
+3% +$71.1K 0.01% 1006
2024
Q2
$2.64M Buy
55,296
+803
+1% +$32.9K 0.01% 874
2024
Q1
$2.36M Sell
54,493
-5,137
-9% -$245K 0.01% 906
2023
Q4
$3.02M Buy
59,630
+1,630
+3% +$78.1K 0.01% 855
2023
Q3
$2.63M Sell
58,000
-6,426
-10% -$265K 0.01% 860
2023
Q2
$2.64M Sell
64,426
-5,793
-8% -$223K 0.01% 901
2023
Q1
$2.51M Sell
70,219
-6,126
-8% -$230K 0.01% 918
2022
Q4
$2.88M Buy
76,345
+222
+0.3% +$9.34K 0.01% 859
2022
Q3
$3.37M Buy
76,123
+780
+1% +$32.9K 0.02% 800
2022
Q2
$2.79M Sell
75,343
-2,323
-3% -$87.6K 0.01% 917
2022
Q1
$2.88M Sell
77,666
-6,995
-8% -$229K 0.01% 978
2021
Q4
$2.58M Sell
84,661
-2,783
-3% -$87.6K 0.01% 1035
2021
Q3
$2.93M Buy
87,444
+7,390
+9% +$278K 0.01% 983
2021
Q2
$3.19M Buy
80,054
+10,669
+15% +$418K 0.01% 974
2021
Q1
$3.12M Buy
69,385
+5,191
+8% +$290K 0.01% 916
2020
Q4
$3.63M Buy
64,194
+12,400
+24% +$618K 0.02% 775
2020
Q3
$2.46M Buy
51,794
+1,970
+4% +$109K 0.01% 800
2020
Q2
$2.94M Sell
49,824
-1,748
-3% -$97.2K 0.02% 749
2020
Q1
$2.44M Buy
51,572
+7,741
+18% +$431K 0.02% 755
2019
Q4
$2.65M Sell
43,831
-10,592
-19% -$631K 0.01% 838
2019
Q3
$3.26M Buy
54,423
+832
+2% +$54.2K 0.02% 758
2019
Q2
$3.44M Sell
53,591
-1,457
-3% -$103K 0.02% 741
2019
Q1
$4.47M Buy
55,048
+12,876
+31% +$831K 0.02% 629
2018
Q4
$2.28M Sell
42,172
-1,498
-3% -$76.4K 0.01% 844
2018
Q3
$2.25M Sell
43,670
-3,535
-7% -$166K 0.01% 966
2018
Q2
$1.97M Sell
47,205
-1,513
-3% -$67.1K 0.01% 1045
2018
Q1
$2.15M Sell
48,718
-851
-2% -$43.2K 0.01% 967
2017
Q4
$2.49M Buy
49,569
+92
+0.2% +$5.04K 0.01% 940
2017
Q3
$2.51M Sell
49,477
-1,625
-3% -$85.1K 0.01% 913
2017
Q2
$2.6M Sell
51,102
-221
-0.4% -$10.3K 0.01% 858
2017
Q1
$2.06M Hold
51,323
0.01% 930
2016
Q4
$2.34M Buy
51,323
+1,246
+2% +$49.3K 0.01% 877
2016
Q3
$1.83M Buy
50,077
+5,493
+12% +$172K 0.01% 950
2016
Q2
$1.04M Sell
44,584
-621
-1% -$20K 0.01% 1099
2016
Q1
$1.83M Buy
45,205
+6,829
+18% +$277K 0.01% 853
2015
Q4
$2.38M Sell
38,376
-2,079
-5% -$112K 0.01% 747
2015
Q3
$1.64M Sell
40,455
-7,481
-16% -$387K 0.01% 969
2015
Q2
$2.76M Buy
+47,936
New +$3.05M 0.02% 792

Other funds holding IONS

Ohio Public Employees Retirement System (OPERS)'s IONS Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Ionis Pharmaceuticals (IONS) stake by 3.3% in Q1 2026, selling an estimated $124K and leaving 46,030 shares worth $3.46M. The position accounts for 0.01% of the portfolio, ranked #826.

Ohio Public Employees Retirement System (OPERS) first reported a position in IONS in Q2 2015 and has held it in 44 quarters since. The position peaked at $4.47M in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 46,030 shares of Ionis Pharmaceuticals worth $3.46M as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 1,568 Ionis Pharmaceuticals shares in Q1 2026, an estimated $124K.
  • Ionis Pharmaceuticals made up 0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #826 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Ionis Pharmaceuticals position peaked at $4.47M in Q1 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.